223 related articles for article (PubMed ID: 37634682)
1. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
2. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
3. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
[TBL] [Abstract][Full Text] [Related]
6. Effects of Active Vitamin D or FGF23 Antibody on
Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES
J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518
[TBL] [Abstract][Full Text] [Related]
7. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.
Boukpessi T; Hoac B; Coyac BR; Leger T; Garcia C; Wicart P; Whyte MP; Glorieux FH; Linglart A; Chaussain C; McKee MD
Bone; 2017 Feb; 95():151-161. PubMed ID: 27884786
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
Carpenter KA; Alkhatib DO; Dulion BA; Guirado E; Patel S; Chen Y; George A; Ross RD
Int J Oral Sci; 2023 Oct; 15(1):47. PubMed ID: 37813865
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin antibody improves alveolar bone quality in the
Ross R; Carpenter K; Alkhatib D; Dulion B; Guirado E; Patel S; Chen Y; George A
Res Sq; 2023 Apr; ():. PubMed ID: 37090634
[TBL] [Abstract][Full Text] [Related]
12. Impaired mineral quality in dentin in X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Penel G; Schmitt A; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Connect Tissue Res; 2018 Dec; 59(sup1):91-96. PubMed ID: 29745817
[TBL] [Abstract][Full Text] [Related]
13. Crossfibrillar mineral tessellation in normal and Hyp mouse bone as revealed by 3D FIB-SEM microscopy.
Buss DJ; Reznikov N; McKee MD
J Struct Biol; 2020 Nov; 212(2):107603. PubMed ID: 32805412
[TBL] [Abstract][Full Text] [Related]
14. Mineral tessellation in mouse enthesis fibrocartilage, Achilles tendon, and Hyp calcifying enthesopathy: A shared 3D mineralization pattern.
Buss DJ; Rechav K; Reznikov N; McKee MD
Bone; 2023 Sep; 174():116818. PubMed ID: 37295663
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin regulates dentin and alveolar bone development and mineralization.
Foster BL; Ao M; Salmon CR; Chavez MB; Kolli TN; Tran AB; Chu EY; Kantovitz KR; Yadav M; Narisawa S; Millán JL; Nociti FH; Somerman MJ
Bone; 2018 Feb; 107():196-207. PubMed ID: 29313816
[TBL] [Abstract][Full Text] [Related]
16. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
Nakanishi T; Yamazaki M; Tachikawa K; Ueta A; Kawai M; Ozono K; Michigami T
Bone; 2024 Apr; 181():117044. PubMed ID: 38331306
[TBL] [Abstract][Full Text] [Related]
17. Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice.
Zhang B; Sun Y; Chen L; Guan C; Guo L; Qin C
Oral Dis; 2010 Jul; 16(5):453-64. PubMed ID: 20233318
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype.
Erben RG; Mayer D; Weber K; Jonsson K; Jüppner H; Lanske B
J Bone Miner Res; 2005 Jul; 20(7):1149-60. PubMed ID: 15940367
[TBL] [Abstract][Full Text] [Related]
19. SPR4-peptide alters bone metabolism of normal and HYP mice.
Zelenchuk LV; Hedge AM; Rowe PS
Bone; 2015 Mar; 72():23-33. PubMed ID: 25460577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia.
Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D
Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
